Metrics to compare | ANUH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANUHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.2x | 29.7x | −0.4x | |
PEG Ratio | −3.96 | 0.78 | 0.00 | |
Price/Book | 2.2x | 4.2x | 2.6x | |
Price / LTM Sales | 1.0x | 3.4x | 3.1x | |
Upside (Analyst Target) | - | 13.5% | 48.9% | |
Fair Value Upside | Unlock | 3.1% | 6.2% | Unlock |
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic, anti platelet, anti-histamines, and intermediates; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, and anti-mitotic. The company also develops products, such as anticoagulant, antagonist, anti convulsants, anty-ulcerative, anty-ulcerative, anticholinergics, anti-anemic, antidepressant, and mucolytic agents. It also exports its products. Anuh Pharma Limited was incorporated in 1960 and is headquartered in Mumbai, India.